It's been quite a year for dermatology, and many issues face the market as it continues its forward path of improving the quality of care as well as the quality of its delivery system.
HS Treatment Response Rates Continue to Improve with Secukinumab at Week 52
The Cutaneous Connection: JAK Inhibitor Safety for Treating AD
Losing a Malpractice Case May Depend on Where You Live
The Cutaneous Connection: Treating Atopic Dermatitis in the Winter
The Role We Play in Addressing Racial Disparity in Dermatology
The Mainstream Patient: February 2